InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Kalofonos Isabel, Directeur Commercial. Director active across 1 company, notably Crinetics Pharmaceuticals, Inc.. Aggregated, 4 disclosures have been logged. Activity tracked since 5 January 2026. The latest transaction was filed on 1 September 2026 (Disposition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Kalofonos Isabel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
1,669 股@ US$85.000.0016% mcap4.5% 占其流量Common StockSEC:0001628280-26-059885:0
34,000 股@ US$85.000.032% mcap92.3% 占其流量Common StockSEC:0001628280-26-059885:1
34,000 股0Common StockSEC:0001628280-26-011715:0
2,500 股@ US$40.590.0011% mcap50.0% 占其流量Common StockSEC:0001628280-26-001230:0
4 条申报中的 4 条
About Kalofonos Isabel
Isabel Kalofonos serves as Chief Commercial Officer at Crinetics Pharmaceuticals, Inc. She is responsible for the company's commercial strategy and business development. Isabel brings expertise in sales management and business strategy, enabling her to drive growth initiatives. Her role is essential for achieving Crinetics' performance objectives.
